Admission of Further Securities to Trading
OCTOPUS AIM VCT 2 PLC
Admission of Further Securities to Trading
Further to the Company's Issue of Equity and Total Voting Rights announcement on 1 April 2026 in respect of the allotment of new Ordinary Shares under the Company's Dividend Reinvestment Scheme and following the admission to trading of those new Ordinary Shares, the following additional information is disclosed in accordance with The Public Offers and Admissions to Trading Regulations 2024 (POATRs) PRM 1.6.4R.
| 1 | Details of the issuer | |
| a) | Name | Octopus AIM VCT 2 plc |
| b) | LEI | 213800BW27BKJCI35L17 |
| 2 | Details of the transferable securities admitted to trading | |
| a) | Name, type and identification code | Ordinary shares of 0.01p each ISIN: GB00B0JQZZ80 |
| b) | Regulated market | London Stock Exchange – Main Market |
| c) | Number of further securities admitted | 4,292,426 |
| d) | Total number of securities in issue following admission | 219,499,240 |
| e) | Fungibility | Fully fungible with existing Ordinary shares |
| 3 | Admission details | |
| a) | Date of admission | 9 April 2026 |
| b) | Prospectus information | Prospectus: N/A Supplementary: N/A Company’s webpage: https://octopusinvestments.com/our-products/venture-capital-trusts/octopus-aim-vcts/ |
| c) | Coverage of notification | All admissions up to and including 1 April 2026 |
For further information please contact:
Andrew Humphries
Octopus Company Secretarial Services Limited
Tel: +44 (0)80 0316 2067
LEI: 213800BW27BKJCI35L17
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Structure Research: AI Data Centre Capacity to Surge from 2.3 GW to 150 GW by 2030
- The FDA Publishes Its Supplement Warning Letters, NutraVeri Built the Tool That Reads Them Before You Receive One
- BL Companies Expands Wilmington Office to Support Growth in the Carolinas
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share